Esculetin unveiled: Decoding its anti-tumor potential through molecular mechanisms-A comprehensive review

Md Rezoan Hossain1, Fatema Tuj Zahra Shova2, Munni Akter3

  • 1Biochemistry and Molecular Biology, Rajshahi University, Rajshahi, Bangladesh.

PubMed
Abstract

Insights

Esculetin, a natural compound, shows significant anticancer activity against 16 cancer types by modulating key cellular processes. Its nanoformulation and synergistic effects enhance efficacy and reduce side effects, positioning it as a promising cancer therapeutic.

Area of Science:

  • Natural product chemistry
  • Pharmacology
  • Oncology

Background:

  • Cancer complexity necessitates novel therapeutic strategies.
  • Existing treatments face limitations including side effects.
  • Natural compounds offer alternative approaches with improved safety profiles.

Purpose of the Study:

  • To comprehensively review esculetin's anticancer properties.
  • To detail its molecular and cellular mechanisms of action.
  • To evaluate its potential as a cancer therapeutic.

Main Methods:

  • Literature review of in vivo and in vitro studies on esculetin.
  • Analysis of esculetin's effects on cancer hallmarks.
  • Investigation of nanoformulation and synergistic strategies.

Main Results:

  • Esculetin exhibits efficacy against 16 cancer types.
  • It modulates critical pathways including proliferation, apoptosis, and angiogenesis.
  • Nanoformulation enhances solubility and efficacy; synergistic use reverses resistance.

Conclusions:

  • Esculetin demonstrates broad-spectrum anticancer activity.
  • It possesses favorable pharmacokinetic and safety profiles.
  • Esculetin is a promising candidate for cancer therapy.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K